Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension study
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-211873
Abstract: Objectives To determine the long-term safety and efficacy of allopurinol dose escalation (DE) to achieve target serum urate (SU) in gout. Methods People, including those with chronic kidney disease, who completed the first 12 months of… read more here.
Keywords: serum urate; allopurinol dose; dose escalation; extension study ... See more keywords
THU0608 Association between allopurinol dose-titration and serum uric acid levels in gout patients: us electronic health record data
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.6314
Abstract: Background Allopurinol is a first-line urate lowering therapy for patients with gout. The American College of Rheumatology guidelines recommend allopurinol dose-titration to maintain serum uric acid (sUA) levels TD), or no-dose-change (ID = TD). For… read more here.
Keywords: allopurinol dose; titration; employee; dose titration ... See more keywords